Ignite Creation Date:
2025-12-25 @ 12:52 AM
Ignite Modification Date:
2025-12-25 @ 11:07 PM
Study NCT ID:
NCT01758367
Status:
UNKNOWN
Last Update Posted:
2016-08-31
First Post:
2012-12-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Decitabine Followed by Donor Lymphocyte Infusion for Patients With Relapsed Acute Myeloblastic Leukemia(AML) After Allogeneic Stem Cell Transplantation
Sponsor:
Chinese PLA General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-12
Start Date Type:
None
Primary Completion Date:
2017-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-06
Completion Date Type:
ESTIMATED
First Submit Date:
2012-12-27
First Submit QC Date:
None
Study First Post Date:
2013-01-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-08-29
Last Update Post Date:
2016-08-31
Last Update Post Date Type:
ESTIMATED